Comparison of Topical Versus Intravenous Tranexamic Acid in TKA
NCT02393300
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
174
Enrollment
OTHER
Sponsor class
Conditions
Total Blood Loss
Interventions
DRUG:
normal saline
DRUG:
Tranexamic Acid
DRUG:
Tranexamic Acid
Sponsor
Shanghai Jiao Tong University School of Medicine